Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moingeon

Vaccine

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Vaccine|February 13, 2001
Cancer vaccinesP Moingeon
Vaccine|August 3, 2001
Towards the rational design of Th1 adjuvantsP Moingeon, J Haensler, A Lindberg
Vaccine|March 21, 2001
Therapeutic vaccines against melanoma and colorectal cancerJ Tartaglia, M C Bonnet, N Berinstein, et al.
Vaccine|February 13, 2001
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesB Rosenwirth, E M Kuhn, J L Heeney, et al.
Vaccine|July 11, 2012
Anti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammationT Batard, A Zimmer, E Nony, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Vaccine|February 13, 2001
Cancer vaccinesP Moingeon
Vaccine|August 3, 2001
Towards the rational design of Th1 adjuvantsP Moingeon, J Haensler, A Lindberg
Vaccine|March 21, 2001
Therapeutic vaccines against melanoma and colorectal cancerJ Tartaglia, M C Bonnet, N Berinstein, et al.
Vaccine|February 13, 2001
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesB Rosenwirth, E M Kuhn, J L Heeney, et al.
Vaccine|July 11, 2012
Anti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammationT Batard, A Zimmer, E Nony, et al.
Pageof 1